Investor Presentation • May 12, 2025
Investor Presentation
Open in ViewerOpens in native device viewer

May 2025 - 1 - 1

This presentation was prepared by New Med Partnership" (the "Partnership") based on information included in the immediate and periodic reports fied by the Partnership with the Israel Securities Authority and the Tel Aviv Stock Exchange Ltd. under the Securities Law, 5726-1968.
The presentation is intended to present the Partners and provide general information regarding its main activities in a user-friendly and clear manner. By its rature, the presentation is concise and does not include all information and data published by the Securities Law 5728-1968.
To chain a full picture of the Partnership and the risks entalled thereby see the full immediate and periodic reports fleet by the Partnership with the Israel Securities Authority and the Fel vir Stock in the Partnership's Annual Report of 2024 as published by the Partnership on 10 March 2025 (Reference No: 2025-01-015633) (the "Annual Report").
The presentation includes for ware on as defined in the Securities Law, 5728-1968 Such formation may not materialize, in whole of in part, or may materialize differently than expected, or may be affected by factors that cannot be assessed in advance.


| Israel | Egypt | Jordan | Total | |
|---|---|---|---|---|
| 1Q / 2025 (BCM) | 0.4 | 1.7 | 0.8 | 2.9 |
| Average Price (\$/mmbtu) | 5.85 | |||
| 1Q / 2024 (BCM) | 0.2 | 1.8 | 0.6 | 2.6 |
| Average Price (\$/mmbtu) | 6.16 |

* Production Summary for Leviathan 100%









| For the period | 1-3/2025 | 1-3/20124 | 2024 |
|---|---|---|---|
| Revenues From natural gas and condensate sales | 287.6 | 263.2 | 1,136.3 |
| Net of royalties | 42.0 | 37.1 | 163.2 |
| Revenues, net | 245.6 | 226.1 | 973.1 |
| Expenses and costs: | |||
| Cost of production of natural gas and condensate | 37.8 | 44.4 | 168.4 |
| Depreciation, depletion and amortization expenses | 22.6 | 19.0 | 80.7 |
| Other direct expenses | 3.1 | 0.8 | 5.9 |
| G&A | 3.2 | 3.2 | 16.9 |
| Total expenses and costs | 66.7 | 67.4 | 271.9 |
| The Partnership's share in the losses / Profits of entities accounted for at equity | (0.7) | 1.0 | 2.9 |
| Operating profit | 178.2 | 159.7 | 704.1 |
| Financial expenses | (31.9) | (29.6) | (113.8) |
| Financial income | 6.2 | 27.4 | 90.9 |
| Financial expenses, net | (25.7) | (2.2) | (22.9) |
| Profit before income taxes | 152.5 | 157.5 | 681.2 |
| Taxes on income | (36.1) | (36.4) | (156.6) |
| Profit from continued operation | 116.4 | 121.1 | 524.6 |
| Total profit from discontinued operations | * | ||
| Net income | 116.4 | 121.1 | 524.6 |



| For the Period Ending | 31.03.2025 | 31.03.2024 | 31.12.2024 |
|---|---|---|---|
| Assets: | |||
| Current assets: | |||
| Cash and cash equivalents | 99.7 | 152.3 | 51.2 |
| Short-term deposits | 337.7 | 89.5 | 333.3 |
| Trade receivables | 226.2 | 226.1 | 209.6 |
| Trade and other receivables | 124.6 | 146.3 | 140.0 |
| 788.2 | 614.2 | 734.1 | |
| Non-current assets: | |||
| Investments in oil and gas assets | 2,703.1 | 2,645.5 | 2,682.3 |
| Investments in entities accounted for at equity | 61.0 | 59.3 | 61.7 |
| Long-term deposits | 0.8 | 103.1 | 0.5 |
| Other long-term assets | 508.7 | 481.9 | 513.7 |
| 3,273.6 | 3,289.8 | 3,258.2 | |
| 4,061.8 | 3,904.0 | 3,992.3 | |
| Liabilities and equity: | |||
| Current liabilities: | |||
| Current maturities of bonds | 445.9 | 485.6 | |
| Declared profit distribution | 60.0 | ||
| Income tax payable | 5.9 | 17.9 | 10.8 |
| Trade and other payables | 147.1 | 121.2 | 106.6 |
| Other short-term liabilities | 2.3 | ||
| 598.9 | 201.4 | 603.0 | |
| Non-current liabilities: | |||
| Bonds | 1,140.6 | 1,728.1 | 1,140.0 |
| Deferred taxes | 402.8 | 330.6 | 391.5 |
| Other long-term liabilities | 75.7 | 70.1 | 70.5 |
| 1,619.1 | 2,128.8 | 1,602.0 | |
| Equity: | |||
| Partners' equity | 154.8 | 154.8 | 154.8 |
| Capital reserves | (28.0) | (28.4) | (28.1) |
| Retained earnings | 1,717.0 | 1,447.4 | 1,660.6 |
| 1,843.8 | 1,573.8 | 1,787.3 | |
| 4,061.8 | 3,904.0 | 3,992.3 |

Dividend Distributions

* Including latest declared Dividend and tax balancing distribution
NewMed Energy- IR Tel. +972 9 971 2421 [email protected]

| QUARTER ENDED | 31.03.2025 | |
|---|---|---|
| QUANTITY/ACTUAL | ||
| AMOUNT (IN USD\$ ,000) | ||
| Total Offtake (BCM) | 2.9 | |
| Leviathan Revenues (100%) | 634,220 | |
| Loss Proceeds, if any, paid to Revenue Account | ||
| Sponsor Deposits, if any, into Revenue Account | ||
| Gross Revenues (before Royalties) | 273,638 | |
| Overriding Royalties | ||
| Statutory Royalties | (31,410) | |
| (b) Third Party Royalties | (12,565) | |
| Net Revenues | 229,663 | |
| Costs and Expenses: | ||
| Fees Under the Financing Documents (Interest Income) | 803 | |
| Taxes | (62,655) | |
| Operation and Maintenance Expenses | (36,664) | |
| Capital Expenditures | (19,102) | |
| Insurance (income) | ||
| Total Costs and Expenses (sum of Items H(a), (b), (c), (d) and (e)) | (117,618) | |
| Total Cash Flows Available for Debt Service (Item G minus Item H) | 112,045 | |
| Total Cash Flow from operation (Item G minus Items H(c) and H(e) | 192,999 | |
| Total Debt Service | 35,184 | |
| Total Distribution to the Sponsor | 75,000 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.